Trevi Therapeutics, Inc.(NasdaqGM:TRVI) added to Russell Small Cap Comp Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.86 USD | -2.39% | +7.92% | +113.43% |
Mar. 20 | Transcript : Trevi Therapeutics, Inc., Q4 2023 Earnings Call, Mar 20, 2024 | |
Mar. 20 | Trevi Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.43% | 201M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.87% | 22.25B | |
-14.77% | 21.68B | |
-8.98% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- TRVI Stock
- News Trevi Therapeutics, Inc.
- Trevi Therapeutics, Inc.(NasdaqGM: TRVI) added to Russell Small Cap Comp Value Index